Clicks Group Limited Stock

Equities

CLS

ZAE000134854

Drug Retailers

End-of-day quote Johannesburg S.E. 18:00:00 2024-05-30 EDT 5-day change 1st Jan Change
295.8 ZAR -1.08% Intraday chart for Clicks Group Limited -4.58% -9.20%

Financials

Sales 2024 * 45.62B 2.43B 3.31B Sales 2025 * 49.77B 2.65B 3.61B Capitalization 70.41B 3.75B 5.11B
Net income 2024 * 2.82B 150M 204M Net income 2025 * 3.11B 166M 226M EV / Sales 2024 * 1.51 x
Net cash position 2024 * 1.75B 93.39M 127M Net cash position 2025 * 2.18B 116M 158M EV / Sales 2025 * 1.37 x
P/E ratio 2024 *
25.2 x
P/E ratio 2025 *
22.7 x
Employees 18,741
Yield 2024 *
2.58%
Yield 2025 *
2.9%
Free-Float 79.51%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.08%
1 week-4.58%
1 month+0.47%
3 months-0.90%
6 months+0.16%
Current year-9.20%
More quotes
1 week
295.00
Extreme 295
309.80
1 month
293.06
Extreme 293.06
314.00
Current year
275.50
Extreme 275.5
328.05
1 year
235.56
Extreme 235.56
328.05
3 years
232.63
Extreme 232.63
329.43
5 years
185.53
Extreme 185.53
329.43
10 years
58.67
Extreme 58.67
329.43
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 06-06-30
Director of Finance/CFO 52 05-12-31
Corporate Officer/Principal 50 05-12-31
Members of the board TitleAgeSince
Director/Board Member 61 23-06-30
Chairman 74 95-12-31
Director/Board Member 62 22-08-31
More insiders
Date Price Change Volume
24-05-31 295.8 -1.08% 2,082,589
24-05-30 299 -2.27% 1,016,878
24-05-28 305.9 +0.15% 460,425
24-05-27 305.5 -1.44% 350,727

End-of-day quote Johannesburg S.E., May 30, 2024

More quotes
Clicks Group Limited specializes in distributing health, care and beauty products. Net sales (including intragroup) break down by activity as follows: - retail distribution (64.9%): sale of pharmaceutical products, care and beauty products and music equipment. At the end of August 2023, the group operated a network of 1,140 stores under the Clicks (881), the Sorbet (194), The Body Shop (61) and the Clicks Baby (4) brand names located mainly in South Africa (1,087); - wholesale distribution of pharmaceutical products (35.1%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
295.8 ZAR
Average target price
317.7 ZAR
Spread / Average Target
+7.42%
Consensus